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Abstract 
Proteomic differences between rat dams and control mothers deprived of their pups 
immediately after delivery were investigated in the medial prefrontal cortex (mPFC). 
A 2-D DIGE minimal dye technique combined with LC-MS/MS identified 32 
different proteins that showed significant changes in expression in the mPFC, of which, 25 
were upregulated and 7 were downregulated in dams. The identity of one significantly 
increased protein, the small heat-shock protein alpha-crystallin B chain (Cryab), was 
confirmed via Western blot analysis. Alpha-crystallin B chain was distributed in scattered 
cells in the mPFC, as demonstrated by immunohistochemistry. Furthermore, it was found to 
be localized in parvalbumin-containing neurons using double labeling. The elevation of its 
mRNA level in rat dams was also demonstrated via RT-PCR. 
The functional classification of the altered proteins was conducted using the UniProt 
and Gene Ontology protein databases. The identified proteins predominantly participate in 
synaptic transport and plasticity, neuron development, oxidative stress and apoptosis, and 
cytoskeleton organization. A common regulator and target analysis of these proteins 
determined using the Elsevier Pathway Studio Platform suggests that protein level changes 
associated with pup nursing are driven by growth factors and cytokines, while the MAP 
kinase pathway was identified as a common target. A high proportion of the proteins that 
were found to be altered in the mPFC are associated with depression. 
 
Biological significance 
The behavior and emotional state of females change robustly when they become 
mothers. The brain, which governs these changes, may also undergo molecular alterations in 
mothers. As no proteomics approaches have been applied regarding maternal changes in the 
brain, we addressed this issue in the mPFC as this brain area is the uppermost cortical center 
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of maternal control and the associated mood changes. The high number of protein-level 
alterations found between mothers taking care of their litter and those without pups indicates 
that pup nursing is associated with cortical protein-level changes. Alterations in proteins 
participating in synaptic transport, plasticity and neuron development suggest neuroplastic 
changes in the maternal brain. In turn, the relatively high number of altered proteins in the 
mPFC associated with depression suggests that the physiological effects of the protein-level 
alterations in the maternal mPFC could promote the incidence of postpartum depression. 
Alpha-crystallin B chain, a protein confirmed to be increased during maternal behaviors, was 
selectively found in parvalbumin cells, which, as fast-spiking interneurons, are associated 
with depression. The function of alpha-crystallin B chain should be further investigated to 
establish whether it can be used to identify drug targets for future drug development.  
 
Keywords: maternal behavior, depression, 2-D DIGE, alpha-crystallin B chain - Cryab, 
synaptic transport and plasticity, common regulator and target analysis, parvalbumin positive 
GABAergic interneurons 
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Introduction 
The behavior and the emotional state of females changes immensely as they become 
mothers. Female rats avoid or even hurt pups, while mothers take care of their pups and 
defend them against intruders [1]. Maternal behaviors in postpartum rats include nest building, 
the retrieval of pups to the nest, the licking of pups, and the adoption of appropriate postures 
for suckling [2]. These behavioral alterations are accompanied with reduced anxiety- and 
depression-like behaviors, and increased aggressiveness towards intruders [3-5]. The highest, 
cortical control influencing maternal responses implies the involvement of the medial 
prefrontal cortex (mPFC) in maternal adaptations [6-8]. In addition, the mPFC is part of the 
limbic system and is associated with emotional changes, including anxiety, stress responses, 
and depression, as well as aggression [9-15]. Impaired maternal responsiveness in human 
mothers suffering from postpartum depression (PPD) has been shown to be associated with 
reduced activity in brain areas corresponding to the mPFC [16-18]. Approximately 13% of 
women experience PPD within 14 weeks after giving birth [19], and 19% of women 
experience a depressive episode during pregnancy or during the first 3 months postpartum 
[20]. PPD has both immediate and long-term effects on a mother’s mental health, as well as 
negative effects on the development of their children [21-23]. Women suffering from PPD 
display a disturbed mother-infant relationship, decreased responsiveness to the demands of 
parenting, mood disorders, symptoms of anxiety and confusion [24,25]. During the pregnancy 
and postpartum, mothers have to face new problems. An elevated anxiety and stress level at 
the time of pregnancy are one of the major risk factors for PPD [26,27]. These stressful factors 
can increase a mother’s vulnerability and the onset of mental illness [28,29]. 
While the involvement of the mPFC in orchestrating maternal behavior and related 
emotional changes is well-established, little is known about the underlying molecular 
mechanisms except that the maternal alterations are not simply due to changes in hormone 
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levels [2,30,31]. Estrogen and progesterone contribute to maternal adaptations during 
pregnancy, but they are not required for the maintenance of maternal responsiveness, and 
even ovariectomized female rats can be induced into a fully maternal state by prolonged pup 
exposure [1]. Furthermore, motivational and emotional states also change in rats in the 
postpartum period [32,33]. Therefore, we hypothesized that the behavioral and emotional 
changes in rat mothers are accompanied by alterations in the brain at the protein level. 
Because proteomics has not been applied to reveal protein-level alterations in the maternal 
brain, we compared protein levels in brain tissue homogenates from maternal and non-
maternal rats. One group of animals consisted of mother rats 11-12 days after parturition. To 
focus on protein-level changes associated with maternal care and eliminate pregnancy-
induced alterations, the control group consisted of mother rats whose litter was removed 
immediately after delivery. These rats no longer show maternal behaviors by the time the 
brain tissue samples were collected [34], but they went through pregnancy, parturition and all 
of the associated hormonal changes prior to litter removal. 
 
Methods 
Animals 
Animals were kept under standard laboratory conditions with 12-hour light and dark 
periods (lights were on from 08.00 am to 08.00 pm). Food and water were supplied ad 
libitum. The care and experimentation of all animals conformed to the Hungarian Act of 
Animal Care and Experimentation (1998, XXVIII) and to the guidelines of the European 
Communities Council Directive, 86/609/EEC as well as with local regulations for the care and 
use of animals for research. 
A total of 46 adult Wistar rats were used in the study. The number of pups of rat dams 
was adjusted immediately after parturition. In the maternal groups, the litters were adjusted to 
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8 pups, and pups were removed from the control groups (pup-deprived mothers). For 
perfusions and dissections, rats were anesthetized with an intramuscular injection of 
anesthetic mix containing 0.2 ml/300 g body weight ketamine (100 mg/ml) and 0.2 ml/300 g 
body weight xylazine (20 mg/ml) and sacrificed at 11-12 days postpartum. For proteomics, 
Western blot and RT-PCR analyses, the mPFCs were dissected from the freshly removed 
brains. For immunohistochemistry, the rats were transcardially perfused with saline followed 
by 4% paraformaldehyde. 
 
Microdissection of brain tissue samples 
 The brains of 20 mothers with litters and 20 pup-deprived control rats (mothers whose 
pups were removed immediately after parturition) were dissected. Coronal brain sections (2-
mm thick) were prepared with a razor blade. The anterior level of the optic chiasm (bregma 
level: +0.3 mm) was used to determine the antero-posterior levels. For the dissection of the 
mPFC sample, first a coronal section was cut between bregma levels 4.3 and 2.3. 
Subsequently, the ventral 1.5 mm of this section containing the anterior olfactory nucleus was 
removed, and then, vertical cuts were made 1 mm lateral to the midline to include the mPFC 
from both sides of the brain (Figure 1). The dissected tissue samples were quickly frozen on 
dry ice, and stored at -80 
o
C. 
 
Proteomic analysis via two-dimensional differential gel electrophoresis (2-D DIGE) 
For the proteomic analysis, mPFC dissected from 6 mothers with litters and 6 pup-
deprived control rats were used. The details of the 2-D DIGE protocol has been described in 
our previous study [35]. The 2-D DIGE minimal dye labeling method was used. Equipment 
and software were supplied by GE Healthcare, Little Chalfont, UK. Briefly, proteins from the 
homogenized brain tissues were acetone-precipitated and then re-suspended in a lysis buffer 
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containing 7 M urea, 2 M thiourea, 4% CHAPS, 20 mM Tris and 5 mM magnesium-acetate. 
The pH of the samples was adjusted to 8.5, and the protein concentrations were determined 
with a 2-D Quant Kit. Samples (50 µg) were labeled using a CyDye DIGE Fluor Minimal 
Labeling Kit according to the manufacturer’s instructions. The maternal and pup-deprived 
tissue samples were randomly labeled with Cy3 and Cy5, and the internal standard (a pool of 
equal amounts of all samples from the experiment) was labeled with Cy2 fluorescent dye. The 
three differently labeled protein samples were merged, and six mixtures (six simultaneous 
gels) were run. Isoelectric focusing was performed on 24 cm IPG strips (pH 3–10 NL) for 24 
h in an Ettan IPGphor instrument to attain a total of 80 kVh. The voltages applied in each 
mode were as follows: 30 V for a 3 h step, 500 V for a 5 h gradient, 1,000 V for a 6 h 
gradient, 8,000 V for a 3 h gradient, and 8,000 V for a 6 h step. Focused proteins were 
reduced and then alkylated in equilibrating buffers containing mercaptoethanol and 
iodoacetamide, respectively, for 20–20 min. Subsequently, the IPG strips were loaded onto 
10% polyacrylamide gels (24×20 cm), and SDS-PAGE was performed using an Ettan DALT 
Six System. Gels were scanned with a Typhoon TRIO+ scanner, selecting appropriate lasers 
and filters. Gel images were visualized using ImageQuant TL software. A differential protein 
analysis was performed using DeCyder 2D 7.0 software with the Differential In-gel Analysis 
(DIA) and Biological Variance Analysis (BVA) modules. The internal standard contained 
equal amounts from the same sample in all gels, and the changes in fluorescence intensity of 
the protein spots were normalized to the values of the corresponding internal standard. 
Independent Student’s t-tests were performed to determine the statistical significance of 
changes in protein abundance, with a cut-off of p < 0.05 for each protein spot. 
 
Preparative two-dimensional gel electrophoresis for protein identification 
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For the identification of proteins in the spots of interest, a separate preparative two-
dimensional gel electrophoresis was performed using a total of 800 µg of protein per gel. 
Resolved protein spots were visualized using Colloidal Coomassie Blue G-250 (Merck, 
Darmstadt, Germany). 
 
Protein identification by mass spectrometry 
2-D DIGE gel-separated protein spots were cut from the gel and in-gel digested for 
mass spectrometry-based protein identification using the protocol available on-line 
(http://msf.ucsf.edu/protocols.html). After reduction with dithiothreitol (DTT) and alkylation 
with iodoacetamide (IAM) the proteins were digested with trypsin (sequencing rate modified 
trypsin from pig pancreas, Promega). Tryptic peptides were subjected to LC-MS/MS analysis 
on an LCQ-Fleet ion trap mass spectrometer (Thermo) coupled in-line with a nanoAcquity 
HPLC system (Waters). Peptide extracts (5 µl of the 10 µl sample) were injected into the 
nano-HPLC system using a trap column (Symmetry C18, 0.18×20 mm, 5 µm, Waters) and 
were analyzed in a BEH300C18 1.7 um (0.1 × 100 mm) nanoAcquity UPLC column (Waters) 
using a gradient elution (10-40% B solution over 30 minutes, B solution: 0.1 % formic acid in 
acetonitrile, A solution: 0.1% formic acid in water). MS data were acquired in a data-
dependent fashion using a triple play method, with each survey scan followed by zoom scans 
and CID scans (normalized collision energy: 35) of the 3 most abundant, multiply charged 
precursor ions. Dynamic exclusion was set to 30 sec. Mascot Distiller (ver: 2.2.1.0) was used 
to generate the MS/MS peak list files (mgf) from the raw data and the ProteinProspector (v. 
5.3.0.) search engine was used for the database search. We used the following parameters for 
the search: database: UniProtKB.2011.03.30 HUMAN RODENT (218476/14423061 entries 
searched); enzyme: trypsin with maximum 2 missed cleavage sites; fixed modifications: 
carbamidomethyl (C); variable modifications: acetyl (protein N-term), Gln->pyro-Glu (N-
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term Q), oxidation (M); peptide mass tolerance: ± 0.6 Da; fragment mass tolerance: ± 1 Da. 
Proteins identified with at least with 2 unique peptides (minimum peptide score: 15) were 
considered as a valid hit. 
 
Functional clustering 
Significantly altered proteins were clustered on the basis of the protein annotations in 
the UniProt (http://www.uniprot.org/) and Gene Ontology (http://geneontology.org/) 
databases. The proteins were clustered into groups according to their most relevant cellular 
functions. 
 
Bioinformatic analysis of significant protein changes  
The interactions between significantly altered cortical proteins were analyzed using 
the Elsevier Pathway Studio Platform. We selected common regulator and target proteins 
having a minimum of 4 relationships with the significantly altered maternal proteins from the 
experimental results. For further analysis, common regulators and targets connected with 
Cryab were selected.  
 
Validation of the significantly altered proteins via Western blot (WB) analysis 
For Western blotting, mPFC dissected from 6 mothers with litters and 6 pup-deprived 
control rats were used. The protein with highest fold change in expression level in the mPFC 
was shown to be alpha-crystallin B chain (Cryab), thus, we selected it for validation via WB 
analysis. We used the same samples that were utilized in the 2-D DIGE method. Both 
maternal and pup-deprived samples (n=6-6) weighed 100 µg. Proteins were separated with 
Tricine-SDS-polyacrylamide gel electrophoresis on 15% polyacrylamide gels and then 
transferred to Hybond-LFP PVDF transfer membranes (GE Healthcare). The membranes were 
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blocked with 5% BSA in Tris-buffered saline with 0.1 % Tween 20 (TBS-T). The blots were 
incubated with the 1:1 mixture of goat anti-Cryab primary antibody (sc-22391, Santa Cruz 
Biotechnology) at a 1:500 dilution and mouse anti-CoxIV primary antibody at a 1:1,000 
dilution (sc-58348, Santa Cruz Biotechnology). Subsequently, the membranes were washed 
for 4 x 5 min in TBS-T followed by an incubation with a 1:1 mixture of CruzFluor 488 
conjugated anti-goat (1:1,500 dilution, Santa Cruz Biotechnology) and Cy3 conjugated anti-
mouse IgG secondary antibodies (1:2,500 dilution, GE Healthcare). After washing the 
membranes in TBS-T and then in TBS, the bands were visualized using a Typhoon TRIO+ 
scanner. Fluorescence intensities were quantified using ImageQuant TL software. The 
densitometry data for the intensity of each protein band were analyzed with ImageJ software 
(NIH, Bethesda). Densitometric values of the Cryab protein bands were normalized to the 
densities of the CoxIV loading control protein bands of the same sample. Differences between 
maternal and pup-deprived samples were statistically analyzed using independent two-tailed 
Student’s t-test (Prism 5 for Windows, GraphPad Software, Inc., La Jolla, CA). 
 
Quantitative RT-PCR (qRT-PCR) 
For qRT-PCR analysis, mPFC dissected from 8 mothers with litters and 8 pup-
deprived control rats were used. A quantitative real-time RT-PCR analysis was performed for 
Cryab in the maternal and pup-deprived mPFC samples as described previously [36]. The 
total RNA was isolated from the microdissected mPFC using TRIzol reagent (Invitrogen, 
Carlsbad, CA) according to the manufacturer’s instructions. After diluting RNA to 2 g/l, it 
was treated with Amplification Grade DNase I (Invitrogen) and cDNA was synthesized with a 
Superscript II reverse transcriptase kit (Invitrogen), according to the manufacturer’s 
instructions. After a 10-fold dilution, 2.5 µl of the resulting cDNA was used as a template in 
PCR reactions using SYBR Green dye (Sigma, St. Louis, MO). The PCR reactions were 
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performed with a CFX96 Real-time System (Bio-Rad Laboratories, Hercules, CA) using iTaq 
DNA polymerase (Bio-Rad Laboratories) in total volumes of 12.5 µl under the following 
conditions: 95 
o
C for 3 min, followed by 40 cycles of 95
 o
C for 0.5 min, 60 
o
C for 0.5 min and 
72 
o
C for 1 min. There were 4 genes, which did not change between the mother and control 
groups, used as references: Beta actin (Actb), Cytochrome c oxidase subunit IV isoform 1 
(Cox4i1), Glyceraldehyde-3-phosphate-dehydrogenase (Gapdh), and Lactate dehydrogenase 
A (Ldha). The GenBank accession numbers and the primers used in the study are listed in 
Table 1. Primers were used at a final concentration of 200 nM. Cycle threshold values (CT 
values) were obtained from the linear region of the baseline-adjusted amplification curves 
using Bio-Rad CFX Manager software (Bio-Rad Laboratories). The dCT method was used to 
calculate the changes in the expression of Cryab in relation to the average of the 4 reference 
genes. Statistical comparisons (Prism 5 for Windows, GraphPad Software, Inc) were made 
using Student´s t-test. 
 
Immunohistochemistry (IHC) 
For the immunohistochemistry, mother and pup-deprived rats (3-3) were deeply 
anesthetized and fixed with 4% paraformaldehyde via transcardially perfusion. Brains were 
removed and postfixed in 4% paraformaldehyde for 24 h then transferred to 20% sucrose in 
phosphate buffer (PB, pH=7.4) for 48 h. Serial coronal brain sections were cut at 40 µm on a 
sliding microtome. Sections were collected in PB containing 0.05% sodium-azide and stored 
at 4 
o
C. The mPFC sections were incubated in anti-Cryab primary antibody (1:20 dilution) 
followed by a biotinylated anti-goat secondary antibody (1:1,000 dilution, Jackson 
Immunoresearch, West Grove, PA). Visualization was performed using an ABC kit (1:500 
dilution, Vector Laboratories, Burlingame, CA, USA) and a Ni-DAB reaction. For double 
labeling, the visualization of Cryab was performed using FITC-tyramide (1:8,000) 
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amplification followed by incubation with mouse anti-calbindin (1:900 dilution, catalogue 
number: C9848, Sigma) or anti-parvalbumin (1:800 dilution, catalogue number: P3088, 
Sigma) antibodies, which were visualized with Alexa 594-conjugated anti-mouse IgG (1:400 
dilution, Thermo Fisher Scientific, Waltham, MA). Subsequently, the sections were mounted, 
dried, and coverslipped in antifade medium (Prolong Antifade Kit; Molecular Probes).  
 
Histological analysis 
Sections were examined using an Olympus BX60 light microscope equipped with 
fluorescent epi-illumination. Images were captured at a resolution of 2048 by 2048 pixels 
with a SPOT Xplorer digital CCD camera (Diagnostic Instruments, Sterling Heights, MI). 
Confocal images were acquired with a Nikon Eclipse E800 confocal microscope equipped 
with a BioRad Radiance 2100 Laser Scanning System using 20-60 X objectives at an optical 
thickness of 1-3 µm. 
The contrast and sharpness of the images were adjusted using the “levels” and 
“sharpness” commands in Adobe Photoshop CS 8.0. The full resolution of the images was 
maintained until the final versions were adjusted to a resolution of 300 dpi. 
 
 
Results 
 
Proteomic identification of maternally altered proteins 
We detected approximately 1,200 quantitatively measurable spots per gel with 2-D 
DIGE (Minimal Dye labeling) in the mPFC samples from mother and pup-deprived rats. 
There were 45 different protein spots that showed a significant change, among which, 37 
showed higher and 8 showed lower fluorescence intensities in dams than they did in the 
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control animals. Representative 2-D DIGE gel images with differentially expressed protein 
spots from the mPFC samples are shown in Figure 2. Fold changes in the fluorescence 
intensities between the spots of samples collected from mother and pup-deprived rats were in 
the range of -1.60 to 1.86 (Figure 3A). Proteins in the significantly changed spots were 
identified via HPLC-MS/MS. We were able to describe a total of 32 differentially expressed 
proteins in the mPFC (Table 2). Several proteins were present in more than one spot, 
suggesting post-translational modifications or the presence of protein isoforms. Cryab showed 
the greatest increase in protein level in the mPFC (+1.86) samples from dams. The greatest 
decrease in protein level was shown by tubulin-specific chaperone A (Tbca, -1.60). 
 
Functional clusters of maternally altered proteins 
The identified, altered mPFC proteins participate in a variety of cell processes, 
including synaptic transport and plasticity (n=6), neuron development (n=5), protein synthesis 
and folding (n=3), cytoskeleton organization (n=3), response to oxidative stress and apoptosis 
(n=3), cell differentiation (n=2), amino acid metabolism (n=2), cell cycle (n=2), glucose 
metabolism (n=2), protein transport (n=1), transcription (n=1), protein degradation (n=1) and 
ion transport (n=1), according to the Gene Ontology and UniProt classification (Figure 3B).  
 
Common regulators and targets of maternally altered proteins 
In the region of the mPFC, the major Cryab-related common regulators were β-nerve 
growth factor (NGF), insulin-like growth factor I (IGF1), interleukin-1 β (IL-1B), tumor 
necrosis factor (TNF), transcription factor Sp1 (SP1) and cellular tumor antigen p53 (TP53), 
while the major common targets were RAC-alpha serine/threonine-protein kinase (AKT1), 
insulin (INS), mitogen-activated protein kinase 3 (MAPK3) and mitogen-activated protein 
kinase 1 (MAPK1) (Figure 4). 
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Validation of increased level of Cryab 
A WB analysis was performed for Cryab in the mPFC (Figure 5). The protein levels of 
Cryab were significantly increased in dams when compared with levels in control females 
(1.43 ± 0.14, p < 0.01). The normalized Cryab values (Cryab / CoxIV ratio) were also 
significantly increased in dams, showing a smaller extent of increase but at a higher 
significance level (1.25 ± 0.03, p < 0.001). Thus, the results of the WB analysis of the Cryab 
protein confirmed the 2-D DIGE data. 
 
Gene expression level of Cryab 
Mother rats had a 1.63-times higher level of Cryab mRNA than age-matched pup-
deprived female rats in their mPFC samples (Figure 6). The mRNA level of Cryab (expressed 
as the Cryab/average reference gene mRNA ratio) was 0.72 ± 0.10 and 0.44 ± 0.07 in dams 
and pup-deprived females, respectively. These results represent a significant increase in the 
Cryab mRNA level in dams (t-test, p < 0.05). 
 
Localization of Cryab 
We also analyzed the distribution of the Cryab protein in the region of the mPFC of 
maternal and control brains. The density of Cryab-positive cells was higher in the maternal 
mPFC. These cells were most abundant in layer IV of the prelimbic (PrL) and infralimbic (IL) 
cortices. Cryab immunoreactivity was present in parvalbumin-positive GABAergic 
interneurons but not in calbindin-positive cells (Figure 7). The labeling was most intense in 
the perisomatic region of the cells. 
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Discussion 
We present here the first proteomic study of maternal changes in the region of the 
mPFC. First, we discuss the altered proteins based on their functional classifications, 
including the relation of the altered medial prefrontal proteins to depression. Subsequently, 
we focus on a particular protein, Cryab, and the consequences of its localization in the mPFC. 
Finally, the common regulators and targets of the altered proteins are analyzed. 
 
Potential functions of the altered proteins 
Most of the altered proteins identified in rat dams are involved in synaptic transport 
and plasticity (19%), neuron development (16%), the oxidative stress response and apoptosis 
(10%) and cytoskeleton organization (10%) (Figure 3B). These data suggest remarkable 
synaptic alterations, which could be related to the flexibly plasticity of the cerebral cortex or 
the high number of synapses present. Furthermore, the neuronal processes similar to those 
active during development showed an elevated activity level in rat dams.  
The physiological changes that occur in the brain during motherhood require elevated 
protection against stress factors, explaining the oxidative stress- and cytoskeleton 
organization-related protein changes. Many of the significantly altered proteins in the mPFC 
have been suggested to be involved in depression as their level or other properties (e.g. state 
of phosphorylation) have been reported to change in conjunction with human depression or 
rodent depression-like behavior (Table 3). Of the 11 proteins associated with depression that 
we identified as altered in the maternal mPFC, 9 show decreased levels in depressed humans 
or other animals (Table 3). Interestingly, 8 (Cplx1, Cplx2, Nrgn, Ina, Cryab, Ddah1, Glul, 
Stam) of these 9 proteins were present at increased levels in the mPFC of rat dams. The Cryab 
chaperone protein has been shown to have changes in its phosphorylation status in 
dorsolateral prefrontal cortex tissues from patients with major depressive disorder [37]. The 
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expression of complexin-2 (Cplx2), a synaptic vesicle clustering regulator, is decreased in the 
anterior cingulate cortex [38], and the enzyme glutamine synthase (Glul) shows decreased 
expression levels in the cerebral cortex of patients with major depressive disorder [39]. 
Neurogranin (Nrgn), a synaptic plasticity regulator, shows a decreased protein level in the 
hippocampus and prefrontal cortex in association with [40], and decreased protein levels of 
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (Ddah1), a nitric oxide regulator, are 
also associated with depression-like behavior [41]. RCG55706 (Stam), a protein transport 
regulator, shows decreased protein levels in mice hippocampi after exposure to prenatal stress 
[42], while alpha-internexin (Ina), a neuronal morphogenesis-regulating intermediate filament, 
shows decreased protein levels in rat hippocampi following exposure to stress induced by 
terrifying sounds, and both of these responses are risk factors for depression [43]. 
Thus, maternally increased proteins typically show reduced levels in depression. 
These proteins could contribute to the anti-depression-like traits observed in rat dams [32,44]. 
Furthermore, the potential maladaptation of some of these proteins during the maternal 
process could promote the development of depression in human mothers, who have a much 
higher incidence of depression in the postpartum period (~13%) than does the general 
population [19,20]. The value of the correlations demonstrated in this study is increased by 
the lack of previously available specific molecular markers of postpartum depression [45-47]. 
 
Alpha-crystallin B chain (Cryab) and its potential involvement in maternal adaptations 
Cryab showed the highest increase in protein level in the mPFC of rat dams. 
Therefore, we further analyzed its expression level using independent methods, and not only 
validated the initial demonstration of its change at the protein level but also showed that it is 
elevated at the mRNA level. Thus, Cryab could become a specific molecular marker of 
postpartum depression, which is missing at present [45-47]. Cryab is a member of the small 
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heat shock protein (HSP20) family, whose members form large heterooligomeric complexes. 
Cryab also acts as a molecular chaperone. It does not renature and release proteins, but rather 
holds them in large soluble aggregates [48]. The distribution of Cryab shows a high degree of 
heterogeneity: it is most abundant in the lens, and smaller amounts have also been described 
in other tissues, such as those of the heart, skeletal muscle and the brain [49]. The elevated 
expression of Cryab has been found in some neurological diseases where it has been 
suggested to have a neuroprotective function [50,51], although little is known about its 
protective mechanisms [52]. One suggestion relates to the phosphorylation of Cryab, which 
occurs when the cells are exposed to various types of stresses [53]. The phosphorylated forms 
play neuroprotective, anti-apoptotic roles and increase neuronal survival after injury [54]. The 
cytoprotective effects of Cryab are reflected by its capacity to suppress the aggregation of 
denatured proteins, which in turn provides anti-apoptotic protection [48,52]. An alternative 
explanation for the neuroprotective function of Cryab is its modulatory action on lipid 
membrane polymorphism and fluidity [55]. Our current findings provide the first evidence 
that Cryab is elevated in the brains of rat dams. In fact, we identified Cryab from two different 
protein spots in the mPFC, which may be a result of different phosphorylation states of the 
protein (Figure 2). The increased expression of Cryab in the mPFC of rat dams suggests a 
higher level of protection against stress factors in this brain region. Immunohistochemical 
results showed that the density of Cryab-positive cells was the highest in layer IV of the 
prelimbic and infralimbic cortices and that Cryab immunoreactivity showed membrane-
associated localization. We also demonstrated that Cryab is present in parvalbumin-positive 
(PV), and likely GABAergic, fast-spiking interneurons in the mPFC [56]. These cells are 
essential for normal brain function as they can regulate the activity of principal neurons. PV 
interneurons synapse on the cell bodies and axon initial segments of several pyramidal cells to 
regulate their output. Thereby, they can coordinate the activity of large networks in the brain 
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[57-61]. The increased neuroprotection of PV GABAergic interneurons might contribute to 
preserving the function of the medial prefrontal network under stressful conditions in mother 
rats. Fast-spiking PV interneurons are downregulated in a genetic mouse model of depression, 
causing low-gamma oscillation disturbances and depression-like behavior [62]. The increased 
Cryab protein level in PV interneurons and the huge number of proteins that show increased 
levels in dams suggest an elevation in chaperone activity in PV cells. The insufficient activity 
of Cryab in cells involved in depression can thus become a cause of depressive behavior 
during the postpartum period. Examining the putative involvement of Cryab in the 
development of postpartum depression is an intriguing future research goal as Cryab. 
 
Common regulators and targets of the maternally altered proteins 
The common regulator and common target analyses were carried out for all altered 
proteins, albeit with a focus on connections to Cryab. The major common regulators were 
NGF and IGF1 (growth factors), IL-1B and TNF (cytokines), SP1 (a transcription factor) and 
TP53 (a tumor suppressor), suggesting that these regulators play significant roles in the 
adaptation of the maternal mPFC at the protein level (Figure 4A). Specifically, growth factors 
and cytokines influence maternal protein changes, which has not been reported before. 
However, it is becoming increasingly accepted that depression is correlated with the 
dysregulation of immune processes [63]. IL-1B and TNF, both proinflammatory cytokines, 
are known to show elevated levels in association with depression [64]. In addition, IL-1B may 
have an indirect link with postpartum depression through its association with fatigue [65]. 
Thus, IL-1B could take part in the pathophysiology of postpartum depression. Growth factors 
have also been implicated in depression [66], as depression-like behavior has been associated 
with reduced NGF and IGF1 levels in the rat brain [67,68]. Altered NGF levels have been 
shown to increase the risk of developing depression after chronic stress [69], while 
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antidepressant drugs have been shown to have a beneficial impact of on the malfunction of 
IGF1 in adult rats [70]. NGF levels of mothers with postpartum affective disorders are also 
correlated with infant development [71]. The potential effects of NGF and IGF-1 in the brain 
of mothers could be mediated by the altered levels of the proteins we identified in the present 
study. 
The major common targets identified in the mPFC were AKT1, MAPK1, MAPK3 
(protein kinases) and INS (a hormone) (Figure 4B), suggesting the involvement of these 
proteins, and particularly the mitogen activated protein kinase (MAPK) pathway, which is a 
major signaling pathway involved in neuronal plasticity, function and survival in maternal 
adaptations. While the involvement of this pathway in maternal processes has not been 
demonstrated, it has been reported to be associated with depression [72,73]. The inhibition of 
ERK signaling, which initiates the MAPK pathway, can lead to anxiety and depressive 
behaviors [74]. The mRNA level of MAPK1 has been shown to be altered by both 
nortriptyline and escitalopram, which are both used as antidepressants [75]. MAPK 
phosphatase-1 (MKP-1), the key negative regulator of the MAPK cascade, shows a 
significantly increased expression in postmortem hippocampal tissues of patients with major 
depressive disorder [76]. In addition, MKP-1 mRNA levels have been shown to be increased 
in rat and mouse depression models, while antidepressant treatment normalizes its expression 
[76]. Thus, the MAPK pathway could also play a role in postpartum depression.  
 
Conclusion 
Pup nursing is associated with altered levels of a number of proteins in the mPFC. 
Neuronal development and plasticity are the major functional classes to which the altered 
proteins belong. Several maternally altered proteins have been shown to be regulated by 
growth factors, cytokines and signal transduction pathways, while their common targets are 
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some members of the MAP kinase pathway, suggesting their role in the regulation of maternal 
responsiveness. The greatest change in protein level was observed for alpha-crystallin B chain 
(Cryab), which was found to be expressed in parvalbumin-positive neurons, suggesting its 
role in the maternal adaptation of parvalbumin-positive fast-spiking GABAergic interneurons. 
Several proteins that showed increased levels in rat dams in the region of the mPFC are 
known to be downregulated in association with depression, suggesting an anti-depression-like 
effect in the dams. In particular, Cryab is a potential candidate for involvement in mood 
changes in mothers. 
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Figure legends 
 
Fig. 1. Dissection of the medial prefrontal cortex (mPFC) samples. A: The position of the 
coronal section cut as a first step of the mPFC dissection is shown by the 2 vertical lines on 
the schematic side view of the brain. B: The mPFC tissue sample was obtained from the 
coronal section by cuts at the solid lines. Further abbreviations: ac – anterior commissure, 
AON – anterior olfactory nucleus, cc – corpus callosum, Ins – insular cortex, M – motor 
cortex, Pir – piriform cortex. 
 
Fig. 2. Representative 2-D DIGE gel image with labeled locations of significantly altered 
medial prefrontal cortical protein spots. The spot number and the most prevalent identified 
gene in a particular spot are shown. Red and blue circles indicate significantly increased and 
decreased changes in protein spots of dams relative to those of the control animals, 
respectively. 
 
Fig. 3. Fold changes (A) and functional clustering (B) of maternally altered proteins in the 
medial prefrontal cortex. Proteins with fold changes greater than 1.5 are labeled with yellow. 
 
Fig. 4. Common regulator (A) and target (B) analysis of medial prefrontal cortical proteins, 
with a focus on those connected to Cryab. Common regulators: NGF: beta-nerve growth 
factor, IGF1: insulin-like growth factor I, IL-1B: interleukin-1 beta, TNF: tumor necrosis 
factor, SP1: transcription factor Sp1, TP53: cellular tumor antigen p53. Common targets: 
AKT1: RAC-alpha serine/threonine-protein kinase, INS: insulin, MAPK3: mitogen-activated 
protein kinase 3, MAPK1: mitogen-activated protein kinase 1. Edges indicate the 
relationships between common regulators/targets and altered maternal proteins. Red and blue 
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indicate maternal proteins that were significantly increased and decreased, respectively, that 
have common targets or regulators. Full protein names are presented in Table 2. Green 
indicates common regulator (A) or target (B) proteins. 
 
Fig. 5. Alteration in the Cryab protein and Cryab/CoxIV ratio in the medial prefrontal cortex 
of mother and pup-deprived control rats. The level of Cryab protein is significantly higher in 
mothers than in pup-deprived controls. Left: Densitometric values for Cryab and the 
Cryab/CoxIV ratio (n=6-6, Student’s t-test, **: p < 0.01; ***: p < 0.001, means ± s.e.m. are 
shown). Right: representative immunopositive bands of Cryab and CoxIV.  
 
Fig. 6. Alteration in Cryab mRNA expression in the medial prefrontal cortex of mother and 
pup-deprived control rats. The level of Cryab mRNA is significantly higher in mothers than in 
pup-deprived controls. mRNA expression data are expressed as the ratio of Cryab mRNA to 
the average of Actb, Cox4i1, Gapd and Ldha mRNA levels (n=8-8, Student’s t-test, *: p < 
0.05; means ± s.e.m. are shown). 
 
Fig. 7. Distribution of Cryab immunoreactivity in the medial prefrontal cortex (mPFC). 
Cryab-labeled cells are shown in the maternal (A) and pup-deprived (control) female rats (B). 
The cells are abundant in layer IV of the prelimbic (PrL) and infralimbic (IL) cortices. Cryab 
colocalizes with parvalbumin (C) but not with calbindin (D). White arrows point to double-
labeled cells, white arrowheads point to single-labeled Cryab-positive cells, and black 
arrowheads point to single-labeled calbindin-positive calbindin-positive cells. Scale bars: 500 
µm (A, B), 100 µm (C, D). 
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Table 1. The primers used for amplifying genes in the qRT-PCR study. The GenBank 
accession numbers and the position of the primers in the sequences are also indicated. 
 
Table 2. The functional clusters of significantly altered proteins in the medial prefrontal 
cortex of mother rats. The color gradient from red (elevated protein level) to blue (reduced 
protein level) is used to show the differential abundances of the maternally altered proteins 
(the numbers represent the average ratios). Abbreviations: Acc: accession number, AR: 
average ratio, UP: unique peptides number, SC%: sequence coverage percentage, MW: 
molecular weight, pI: isoelectric point. 
 
Table 3. Significant changes in the levels of proteins in the medial prefrontal cortex that are 
involved in depression-like behavior. The color gradient from red (elevated protein level) to 
blue (reduced protein level) is used to show the differential abundances of maternally altered 
proteins (the numbers represent the average ratios). Abbreviations: Acc: accession number, 
AR: average ratio. (References: 1-[77], 2-[37], 3-[78], 4-[79], 5-[38], 6-[80], 7-[40], 8-[81], 9-
[82], 10-[83], 11-[43], 12-[42], 13-[84], 14-[41], 15-[39], 16-[85]). 
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Table 1.  
Gene Forward and reverse primers Genbank accession 
number 
Position of the 
PCR product 
Alpha-crystallin B chain (Cryab) ctacagccacttccctgagc 
acaaacacagcaagcacagg 
NM_012935 136-365 
Beta actin (Actb) agggtgtgatggtgggtatg 
ccagaggcatacagggacaa 
NM_031144 200-515 
Cytochrome c oxidase subunit IV 
isoform 1 (Cox4i1) 
tctacttcggtgtgccttcg 
gtgcccttgttcatctcagc 
NM_017202 135-379 
Glyceraldehyde-3-phosphate-
dehydrogenase (Gapdh) 
tgccactcagaagactgtgg 
gtcctcagtgtagcccagga 
M17701 540-831 
Lactate dehydrogenase A (Ldha) tgcagcagggtttctatgga 
ggacttacacactggagcca 
NM_017025 1139-1443 
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Table 2.  
MEDIAL PREFRONTAL CORTEX 
ID Acc  Gene  Protein name AR t-test UP SC% MW(Da) pI Localisation (GO) 
synaptic transport and plasticity 
194 
P09951 Syn1 Synapsin-1 
1,21 0,0417 15 34,4 73989 9,8 
synapse, Golgi 
219 1,10 0,0023 17 45,0 73989 9,8 
242 
Q63537 Syn2 Synapsin-2 
-1,23 0,0075 16 41,1 63457 8,7 
synapse 246 -1,16 0,0053 14 41,0 63457 8,7 
439 -1,22 0,0147 13 34,6 63457 8,7 
776 
P70566 Tmod2 Tropomodulin-2 
1,09 0,0004 19 45,6 39492 5,3 
cytoplasm 
782 1,12 0,0266 14 41,6 39492 5,3 
1553 P63041 Cplx1 Complexin-1 1,09 0,0298 5 52,2 15122 4,9 
cytoplasm, 
synapse 
1578 Q04940 Nrgn Neurogranin 1,20 0,0499 2 41,0 7496 6,5 
cytoplasm, 
synapse 
1692 P84087 Cplx2 Complexin-2 1,15 0,0354 3 38,1 15395 5,1 
cytoplasm, 
synapse 
neuron development 
232 
P47942 Dpysl2 
Dihydropyrimidinase-related 
protein 2 
1,13 0,0143 12 31,5 62278 6,0 
cytoplasm, 
membrane 
311 1,10 0,0004 24 62,9 62278 6,0 
319 1,08 0,0192 3 6,5 62278 6,0 
322 1,15 0,0055 38 77,8 62278 6,0 
327 1,10 0,0100 36 68,2 62278 6,0 
301 1,10 0,0017 25 66,3 62278 6,0 
341 
Q9JHU0 Dpysl5 
Dihydropyrimidinase-related 
protein 5 
1,12 0,0066 19 44,0 61541 6,6 
cytoplasm 
348 1,09 0,0091 20 54,4 61541 6,6 
894 Q62952 Dpysl3 
Dihydropyrimidinase-related 
protein 3 
1,14 0,0016 18 49,1 61968 6,0 cytoplasm 
344 
P23565 Ina Alpha-internexin 
1,35 0,0198 20 51,1 56116 5,2 
  
neurofilament 
  
346 1,23 0,0441 27 64,0 56116 5,2 
368 1,22 0,0403 31 70,7 56116 5,2 
1394 
P37805 Tagln3 Transgelin-3 
1,12 0,0159 14 70,9 22501 6,8 
nucleus 
1415 -1,14 0,0334 7 41,7 22501 6,8 
response to oxidative stress, apoptosis 
1286 O35244 Prdx6 Peroxiredoxin-6 1,22 0,0065 18 78,6 24819 5,6 cytoplasm 
1420 
P23928 Cryab Alpha-crystallin B chain 
1,80 0,0002 7 34,3 20089 6,8 cytoplasm, 
nucleus 1430 1,86 0,0059 2 21,7 20089 6,8 
1596 Q5U318 Pea15 
Astrocytic phosphoprotein 
PEA-15 
1,47 0,0016 3 30,0 15040 4,9 cytoplasm 
cytoskeleton organisation 
1565 Q6PEC1 Tbca Tubulin-specific chaperone A -1,60 0,0047 8 43,5 12744 5,4 cytoplasm 
544 P85108 Tubb2a Tubulin beta-2A chain 1,13 0,0281 32 67,0 49907 4,8 
cytoplasm, 
nucleus 
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545 P69897 Tubb5 Tubulin beta-5 chain 1,15 0,0224 31 66,2 49671 4,8 
cytoplasm, 
nucleus 
protein synthesis and folding 
307 
O35814 Stip1 
Stress-induced-
phosphoprotein 1 
1,10 0,0020 15 36,6 62571 6,4 cytoplasm, 
nucleus 317 1,13 0,0095 28 48,3 62571 6,4 
354 P28480 Tcp1 
T-complex protein 1 subunit 
alpha 
1,20 0,0030 12 34,0 60360 5,9 cytoplasm 
640 P85834 Tufm 
Elongation factor Tu, 
mitochondrial 
1,15 0,0066 8 23,9 49523 7,2 mitochondrion 
glucose metabolism 
658 P14408 Fh 
Fumarate hydratase, 
mitochondrial 
1,09 0,0032 9 24,9 54464 9,1 mitochondrion 
808 P09117 Aldoc 
Fructose-bisphosphate 
aldolase C 
1,12 0,0002 14 51,0 39284 6,7 
cytoplasm, 
mitochondrion 
amino acid metabolism 
366 O08557 Ddah1 
N(G),N(G)-dimethylarginine 
dimethylaminohydrolase 1 
1,12 0,0041 5 21,4 31426 5,8 
cytoplasm, 
mitochondrion 
719 P09606 Glul Glutamine synthetase 1,12 0,0366 14 41,8 42268 6,6 
cytoplasm, 
mitochondrion 
cell differentiation 
1670 P62775 Mtpn Myotrophin -1,10 0,0253 7 60,2 12861 5,3 
cytoplasm, 
nucleus 
248 Q5RKI0 Wdr1 
WD repeat-containing               
protein 1 
-1,23 0,0255 4 16,7 66182 6,1 
cytoplasm, cell 
projection 
cell cycle 
757 D3ZDH8 Gp1bb Septin 5, isoform CRA_d 1,15 0,0354 17 47,4 43893 6,2 
synapse, plasma 
membrane 
1483 P60841 Ensa Alpha-endosulfine -1,26 0,0476 5 41,3 13335 6,6 cytoplasm 
ion transport 
932 Q99MZ8 Lasp1 
LIM and SH3 domain               
protein 1 
-1,06 0,0146 3 14,1 29971 6,6 cytoplasm 
protein transport 
325 B5DF55 Stam RCG55706 1,16 0,0065 14 30,3 59593 4,7 cytoplasm 
transcription 
883 Q68A21 Purb 
Transcriptional activator 
protein Pur-beta 
-1,13 0,0240 6 45,7 33418 5,3 nucleus 
protein degradation 
1224 Q6AYK6 Cacybp Calcyclin-binding protein 1,12 0,0001 8 48,5 26541 7,6 
cytoplasm, 
nucleus 
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Table 3.  
MEDIAL PREFRONTAL CORTEX 
ID Acc  Gene  Protein name AR Protein - depression connection 
synaptic transport and plasticity 
194 
P09951 Syn1 Synapsin-1 
1,21 Increased Syn1 protein level correlated with depression-like behavior (1)  
219 1,10 
Syn1 showed differential level of phosphorylation in postmortem 
dorsolateral prefrontal cortex tissues from major depressive disorder 
patients (2) 
1553 P63041 Cplx1 Complexin-1 1,09 
Cplx1 showed decreased mRNA level in the hippocampus from 
postmortem bipolar disorder brain (3) 
Cplx1 showed decreased expression after antidepressant paroxetine 
exposure in rat hippocampus (4) 
1692 P84087 Cplx2 Complexin-2 1,15 
Cplx2 showed decreased protein level in the anterior cingulate cortex 
from postmortem major depression brain (5) 
Downregulation of Cplx2 correlated with depression-like behaviour (6) 
1578 Q04940 Nrgn Neurogranin 1,20 
Altered Nrgn phosphorylation and decreased protein level in hippocampus 
and prefrontal cortex are associated with depression-like behaviors in rats 
following forced swim stress (7) 
neuron development 
232 
P47942 Dpysl2 
Dihydropyrimidinase-
related protein 2 
1,13 Dpysl2 showed decreased protein level in the prefrontal cortex of a rat 
model of depression (8) 311 1,10 
319 1,08 
Dpysl2 showed increased protein level in learned helpless rat depression 
model (9) 
322 1,15 
After antidepressant drugs Dpysl2 showed increased level in rat 
hippocampus (10) 
327 1,10 
Dpysl2 showed differential level of phosphorylation and decreased level of 
expression in postmortem dorsolateral prefrontal cortex tissues from 
major depressive disorder patients (2) 
301 1,10 
Dpysl2 protein level decreased in female rat hippocampus following 
exposure to a terrified sound stress that is a risk factor of depression (11) 
344 
P23565 Ina Alpha-internexin 
1,35 
Ina protein level decreased in female rat hippocampus following exposure 
to a terrified sound stress that is a risk factor of depression (11) 
346 1,23 
368 1,22 
response to oxidative stress, apoptosis 
1286 O35244 Prdx6 Peroxiredoxin-6 1,22 
After antidepressant paroxetine exposure Prdx6 showed decreased 
protein level in rat hippocampus (12) 
1420 
P23928 Cryab Alpha-crystallin B chain 
1,80 Cryab showed differential level of phosphorylation in postmortem 
dorsolateral prefrontal cortex tissues from major depressive disorder 
patients (2) 1430 1,86 
1596 Q5U318 Pea15 
Astrocytic phosphoprotein 
PEA-15 
1,47 
Pea-15 protein level increased in antidepressant-treated prefrontal cortex 
of major depression postmortem brains (13) 
amino acid metabolism 
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366 O08557 Ddah1 
N(G),N(G)-dimethylarginine 
dimethylaminohydrolase 1 
1,12 
Decreased Ddah1 protein level correlated with magnesium restriction-
induced depression like behavior (14) 
719 P09606 Glul Glutamine synthetase 1,12 
Glul showed decreased expression level in cerebral cortex from major 
depressive disorder patients (15) 
protein transport 
325 B5DF55 Stam RCG55706 1,16 
Stam showed decreased protein level in mice hippocampus after 
exposure to prenatal stress that is a risk factor of depression (17) 
ion transport 
932 Q99MZ8 Lasp1 
LIM and SH3 domain 
protein 1 
-1,06 
Decreased hippocampal Lasp1 protein level correlated with depression-
like behavior (16) 
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Biological significance 
The behavior and emotional state of females change robustly when they become 
mothers. The brain, which governs these changes, may also undergo molecular alterations in 
mothers. As no proteomics approaches have been applied regarding maternal changes in the 
brain, we addressed this issue in the mPFC as this brain area is the uppermost cortical center 
of maternal control and the associated mood changes. The high number of protein-level 
alterations found between mothers taking care of their litter and those without pups indicates 
that pup nursing is associated with cortical protein-level changes. Alterations in proteins 
participating in synaptic transport, plasticity and neuron development suggest neuroplastic 
changes in the maternal brain. In turn, the relatively high number of altered proteins in the 
mPFC associated with depression suggests that the physiological effects of the protein-level 
alterations in the maternal mPFC could promote the incidence of postpartum depression. 
Alpha-crystallin B chain, a protein confirmed to be increased during maternal behaviors, was 
selectively found in parvalbumin cells, which, as fast-spiking interneurons, are associated 
with depression. The function of alpha-crystallin B chain should be further investigated to 
establish whether it can be used to identify drug targets for future drug development.  
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Highlights 
We identified 32 protein changes in the medial prefrontal cortex (mPFC) of rat dams. 
The most abundant clusters are: synaptic transport and plasticity, neuron development. 
Common regulators are growth factors and cytokines, common target the MAP kinases. 
A number of proteins altered in the mPFC are associated with depression. 
Increase of alpha-crystallin B chain was confirmed, and shown in parvalbumin cells. 
